Contemporary Perioperative Management of Direct Oral Anticoagulants.
Adv Anesth
; 40(1): 93-109, 2022 12.
Article
em En
| MEDLINE
| ID: mdl-36333054
ABSTRACT
Direct oral anticoagulants (DOACs) have rapidly emerged as popular alternatives to warfarin in the setting of nonvalvular atrial fibrillation, prevention and treatment of venous thromboembolism, and secondary prevention of arterial thrombosis. It is now estimated that more patients in the United States take DOACs than warfarin for approved indications. Studies to date have shown that these drugs are similarly efficacious with perhaps a lower bleeding risk than warfarin. The purpose of this review is to provide insight into the currently available DOACs and discuss the management and reversal strategies for patients in the perioperative period.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fibrilação Atrial
/
Tromboembolia Venosa
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article